The Discounted Cash Flow (DCF) valuation of Vivimed Labs Ltd (VIVIMEDLAB.NS) is (79.00) INR. With the latest stock price at 4.90 INR, the upside of Vivimed Labs Ltd based on DCF is -1712.3%.
Based on the latest price of 4.90 INR and our DCF valuation, Vivimed Labs Ltd (VIVIMEDLAB.NS) is a sell. selling VIVIMEDLAB.NS stocks now will result in a potential gain of 1712.3%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 9.5% - 16.2% | 12.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (109.43) - (68.61) | (79.00) |
| Upside | -2333.4% - -1500.2% | -1712.3% |